SCHEMBL8536795

SCHEMBL8536795

O=C(O)CCCC1CCc2ccccc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.54
HTR2C P28335 3/20 0.52
HTR1A P08908 2/20 0.49
SIGMAR1 Q99720 2/20 0.49
ACHE P22303 2/20 0.49
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CYP26A1 O43174 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7167409 0.96 CYP19A1 (0.53) CYP19A1HTR2CHTR1ASIGMAR1ACHE
SCHEMBL27582477 0.94 CYP19A1 (0.52) CYP19A1HTR2CHTR1ASIGMAR1ACHE
SCHEMBL7672871 0.91 CYP19A1 (0.57) CYP19A1HTR2CHTR1ASIGMAR1ACHE
SCHEMBL8643063 0.82 CYP19A1 (0.49) CYP19A1HTR2CHTR1ASIGMAR1ACHE
SCHEMBL8535642 0.82 CYP19A1 (0.58) CYP19A1HTR1ASIGMAR1ACHEALDH1A1
SCHEMBL8536631 0.82 HTR2C (0.52) CYP19A1HTR2CHTR1ASIGMAR1ACHE
SCHEMBL8532071 0.81 ACHE (0.52) CYP19A1HTR2CHTR1ASIGMAR1ACHE
SCHEMBL8756180 0.81 CYP19A1 (0.58) CYP19A1HTR2CHTR1ASIGMAR1ACHE
SCHEMBL4637304 0.81 MTNR1A (0.53) HTR2C
SCHEMBL6689014 0.80 CYP19A1 (0.61) CYP19A1HTR2CHTR1ASIGMAR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5847159-A 1- ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1998-12-08 US disclosed
EP-0825180-A1 1-OMEGA-(3,4-DIHYDRO-2-NAPHTHALENYL)ALKYL] CYCLIC AMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1998-02-25 EP disclosed
US-5288752-A Brain disorders SUNTORY LIMITED (JP) 1994-02-22 US disclosed
EP-0322248-B1 COMPOUNDS EFFECTIVE AGAINST CEREBRAL INSUFFICIENCY SUNTORY LIMITED (JP) 1993-08-04 EP disclosed
US-5179092-A Cognition activators SUNTORY LIMITED (JP) 1993-01-12 US disclosed
US-5057514-A Compounds effective as cerebral schemia treating agents SUNTORY LIMITED (JP) 1991-10-15 US disclosed
EP-0322248-A2 Compounds effective against cerebral insufficiency SUNTORY LIMITED (JP) 1989-06-28 EP disclosed